-
Vanderbilt Innovation Ambassadors Program Bridges Gap Between Research and Commercialization
Vanderbilt’s Innovation Ambassadors Program is transforming how academic discoveries translate into societal impact through a peer-to-peer approach that has become a model for universities nationwide. -
Vanderbilt Innovation Catalyst Fund continues advancing research with new review committee
The Vanderbilt Innovation Catalyst Fund bridges the gap between academic research and real-world applications by supporting projects with commercial and societal potential -
Turning Research into Real-World Impact: New Lunch & Learn Series for Faculty
This fall, the Center for Technology Transfer and Commercialization (CTTC) is launching a new Lunch and Learn series designed to help faculty translate their research discoveries into meaningful, real-world applications. Through this series, researchers will gain valuable insights into innovation,… -
Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia
Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia. -
Vanderbilt announces Innovation Catalyst Fund awardees for February 2025 cycle
Vanderbilt has announced eleven awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential -
Vanderbilt Collaborates with a Global Transportation Company to Advance Mobility Solutions on I-24 Motion
Together, Vanderbilt and Cintra are turning research into innovation—using insights from I-24 MOTION to directly influence Cintra’s product development, business operations, and R&D strategy. -
Seven Vanderbilt Faculty Research Projects Get Innovation Catalyst Funding
Vanderbilt has announced seven awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential.